Decrease in expression of bone morphogenetic proteins 4 and 5 in synovial tissue of patients with osteoarthritis and rheumatoid arthritis

Bone morphogenetic proteins (BMPs) have been identified as important morphogens with pleiotropic functions in regulating the development, homeostasis and repair of various tissues. The aim of this study was to characterize the expression of BMPs in synovial tissues under normal and arthritic conditions. Synovial tissue from normal donors (ND) and from patients with osteoarthritis (OA) and rheumatoid arthritis (RA) were analyzed for BMP expression by using microarray hybridization. Differential expression of BMP-4 and BMP-5 was validated by semiquantitative RT-PCR, in situ hybridization and immunohistochemistry. Activity of arthritis was determined by routine parameters for systemic inflammation, by histological scoring of synovitis and by semiquantitative RT-PCR of IL-1β, TNF-α, stromelysin and collagenase I in synovial tissue. Expression of BMP-4 and BMP-5 mRNA was found to be significantly decreased in synovial tissue of patients with RA in comparison with ND by microarray analysis (p < 0.0083 and p < 0.0091). Validation by PCR confirmed these data in RA (p < 0.002) and also revealed a significant decrease in BMP-4 and BMP-5 expression in OA compared with ND (p < 0.015). Furthermore, histomorphological distribution of both morphogens as determined by in situ hybridization and immunohistochemistry showed a dominance in the lining layer of normal tissues, whereas chronically inflamed tissue from patients with RA revealed BMP expression mainly scattered across deeper layers. In OA, these changes were less pronounced with variable distribution of BMPs in the lining and sublining layer. BMP-4 and BMP-5 are expressed in normal synovial tissue and were found decreased in OA and RA. This may suggest a role of distinct BMPs in joint homeostasis that is disturbed in inflammatory and degenerative joint diseases. In comparison with previous reports, these data underline the complex impact of these factors on homeostasis and remodeling in joint physiology and pathology.

[1]  W. B. van den Berg,et al.  Crucial role of synovial lining macrophages in the promotion of transforming growth factor beta-mediated osteophyte formation. , 2004, Arthritis and rheumatism.

[2]  G. Zych,et al.  Osteogenic Protein-1 (Bone Morphogenetic Protein-7) in the Treatment of Tibial Nonunions: A Prospective, Randomized Clinical Trial Comparing rhOP-1 with Fresh Bone Autograft* , 2001, The Journal of bone and joint surgery. American volume.

[3]  G. Burmester,et al.  Differential expression of cathepsins B and L compared with matrix metalloproteinases and their respective inhibitors in rheumatoid arthritis and osteoarthritis: a parallel investigation by semiquantitative reverse transcriptase-polymerase chain reaction and immunohistochemistry. , 1998, Arthritis and rheumatism.

[4]  H. Geiger,et al.  Expression of multidrug resistance P-glycoprotein in kidney allografts from cyclosporine A-treated patients. , 2001, Kidney international.

[5]  J. Smolen,et al.  Chondrocyte number and proteoglycan synthesis in the ageing and osteoarthritic human articular cartilage , 2003, Annals of the rheumatic diseases.

[6]  C. Archer,et al.  Development of synovial joints. , 2003, Birth defects research. Part C, Embryo today : reviews.

[7]  S. Chubinskaya,et al.  Regulation of osteogenic proteins by chondrocytes. , 2003, The international journal of biochemistry & cell biology.

[8]  Thomas Häupl,et al.  Bone morphogenetic proteins promote cartilage differentiation and protect engineered artificial cartilage from fibroblast invasion and destruction. , 2002, Arthritis and rheumatism.

[9]  S. Chubinskaya,et al.  Age-related changes in cartilage endogenous osteogenic protein-1 (OP-1). , 2002, Biochimica et biophysica acta.

[10]  D. Kingsley,et al.  The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. , 1994, Genes & development.

[11]  S. Ezzat,et al.  Circulating and synovial levels of IGF‐I, cytokines, physical function and anthropometry differ in women awaiting total knee arthroplasty when compared to men , 2005, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[12]  R. Gay,et al.  Interleukin‐16, produced by synovial fibroblasts, mediates chemoattraction for CD4+ T lymphocytes in rheumatoid arthritis , 1998, European journal of immunology.

[13]  I. Sekiya,et al.  Comparison of effect of BMP-2, -4, and -6 on in vitro cartilage formation of human adult stem cells from bone marrow stroma , 2005, Cell and Tissue Research.

[14]  C. Kawcak,et al.  Delivery of growth factors using gene therapy to enhance bone healing. , 2004, Veterinary surgery : VS.

[15]  M. Dougados,et al.  Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis -- results of a 1 year longitudinal arthroscopic study in 422 patients. , 2005, Osteoarthritis and cartilage.

[16]  W. B. van den Berg,et al.  Anabolic and destructive mediators in osteoarthritis. , 2000, Current opinion in clinical nutrition and metabolic care.

[17]  T. Speed,et al.  Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.

[18]  F. Luyten,et al.  Bone morphogenetic proteins 2 and 6, expressed in arthritic synovium, are regulated by proinflammatory cytokines and differentially modulate fibroblast-like synoviocyte apoptosis. , 2003, Arthritis and rheumatism.

[19]  J. Smolen,et al.  Expression of bone morphogenetic protein 6 in healthy and osteoarthritic human articular chondrocytes and stimulation of matrix synthesis in vitro. , 2003, Arthritis and rheumatism.

[20]  G. Karsenty,et al.  The family of bone morphogenetic proteins. , 2000, Kidney international.

[21]  J. Pelletier,et al.  Differential gene expression and regulation of the bone morphogenetic protein antagonists follistatin and gremlin in normal and osteoarthritic human chondrocytes and synovial fibroblasts , 2004 .

[22]  W. B. van den Berg,et al.  Reduction of osteophyte formation and synovial thickening by adenoviral overexpression of transforming growth factor beta/bone morphogenetic protein inhibitors during experimental osteoarthritis. , 2003, Arthritis and rheumatism.

[23]  J. Wozney,et al.  The bone morphogenetic protein family and osteogenesis , 1992, Molecular reproduction and development.

[24]  W. B. van den Berg,et al.  Synovial lining macrophages mediate osteophyte formation during experimental osteoarthritis. , 2004, Osteoarthritis and cartilage.

[25]  C. Kaps,et al.  BMP2 initiates chondrogenic lineage development of adult human mesenchymal stem cells in high-density culture. , 2003, Differentiation; research in biological diversity.

[26]  T. Sakou.  Bone morphogenetic proteins: from basic studies to clinical approaches. , 1998, Bone.

[27]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[28]  Hideki Yoshikawa,et al.  Bone Morphogenetic Protein Signals Are Required for Cartilage Formation and Differently Regulate Joint Development During Skeletogenesis , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[29]  F. Luyten,et al.  Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis. , 2005, The Journal of clinical investigation.

[30]  V. Krenn,et al.  Synovialitis-Score: Histopathologisches Graduierungsschema rheumatischer und nicht-rheumatischer Synovialitiden , 2005, Zeitschrift für Rheumatologie.

[31]  W. Maloney,et al.  Stimulation of BMP-2 Expression by Pro-Inflammatory Cytokines IL-1 and TNF-&agr; in Normal and Osteoarthritic Chondrocytes , 2003, The Journal of bone and joint surgery. American volume.

[32]  W. B. van den Berg,et al.  Differential effects of local application of BMP-2 or TGF-beta 1 on both articular cartilage composition and osteophyte formation. , 1998, Osteoarthritis and cartilage.

[33]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[34]  W. B. Berg.  Joint inflammation and cartilage destruction may occur uncoupled , 2004, Springer Seminars in Immunopathology.